Preventing Persistent Post-Surgical Pain & Opioid Use in Veterans: Effect of ACT

预防术后持续疼痛

基本信息

  • 批准号:
    8748752
  • 负责人:
  • 金额:
    $ 33.98万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-09-01 至 2016-06-30
  • 项目状态:
    已结题

项目摘要

A large number of veterans suffer from distress-based conditions, such as anxiety and depression, putting them at high risk of experiencing persistent pain and prolonged opioid use following surgery. These connections are based on strong and consistent evidence from the literature and our preliminary data. The proposed study adds a 1-day workshop of Acceptance and Commitment Therapy (ACT), followed by an individual “booster” session, to treatment as usual (TAU) to reduce veterans’ risk of persistent pain and prolonged opioid use following surgery. ACT has been shown to be effective in reducing chronic pain, anxiety and depression. This pilot study will establish the feasibility and preliminary efficacy of incorporating ACT into treatment as usual (TAU) to preoperatively target distress-based risk factors. Aim 1 is to establish the feasibility of successfully delivering ACT to at-risk veterans before and after surgery. Aim 2 is to test the preliminary efficacy of ACT on the length and/or amount of pain and opioid use after surgery. Veterans who are anxious or depressed before surgery will be randomly assigned to receive ACT plus TAU or TAU. Outcomes between the two groups will be compared. Aim 3 is to see if PROMIS modules, developed by the National Institute of Health, are useful for assessing pain and other symptoms in veterans. Findings from this study will be used to inform the design and implementation of a larger, well controlled, randomized clinical trial that will evaluate the efficacy of ACT plus TAU for at-risk veterans. This study will take place at the Iowa City VA Health Care System. Veterans scheduled for orthopedic surgery in 1 to 3 months who score high for anxiety or depression will be randomly assigned to attend a 1-day ACT workshop preoperatively, with an individualize “booster” session postoperatively, or to have TAU. Veterans who receive ACT and trainers who provide the treatment will be interviewed to identify barriers and facilitators to providing ACT to at-risk veterans before and after surgery. Other primary outcomes are pain and opioid use after surgery. Factors that may affect these outcomes will also be measured, including anxiety, depression, substance use disorder, post-traumatic stress disorder, and use of other pain meds. We expect to gain important knowledge about ways to best include ACT as part of routine care for veterans requiring surgery and about the preliminary efficacy of ACT for the prevention of persistent pain and prolonged opioid use following surgery.
大量退伍军人患有焦虑和抑郁等基于痛苦的疾病,这使他们在手术后经历持续疼痛和长时间使用阿片类药物的风险很高。这些联系是基于来自文献和我们的初步数据的有力和一致的证据。拟议的研究增加了一个为期一天的接受和承诺治疗(ACT)研讨会,随后是一个单独的“加强”会议,照常治疗(TAU),以减少退伍军人手术后持续疼痛和长期使用阿片类药物的风险。ACT已被证明在减轻慢性疼痛、焦虑和抑郁方面有效。这项试点研究将确定将ACT纳入常规治疗(TAU)的可行性和初步疗效,以术前针对基于痛苦的风险因素。目的1是确定在手术前后向高危退伍军人成功提供ACT的可行性。目的2是测试ACT对术后疼痛持续时间和/或数量以及阿片类药物使用的初步疗效。术前焦虑或抑郁的退伍军人将被随机分配接受ACT加TAU或TAU。比较两组的结果。第三个目标是观察由美国国立卫生研究院开发的PROMIS模块是否对评估退伍军人的疼痛和其他症状有用。这项研究的结果将用于设计和实施一项更大的、控制良好的随机临床试验,以评估ACT加TAU对高危退伍军人的疗效。这项研究将在爱荷华市退伍军人医疗保健系统进行。计划在1至3个月内进行骨科手术的焦虑或抑郁评分较高的退伍军人将被随机分配参加为期1天的ACT研讨会,并在术后进行个体化的“加强”会议,或进行TAU。接受ACT治疗的退伍军人和提供治疗的培训师将接受采访,以确定在手术前后向有风险的退伍军人提供ACT治疗的障碍和促进因素。其他主要结果是术后疼痛和阿片类药物的使用。可能影响这些结果的因素也将被测量,包括焦虑、抑郁、物质使用障碍、创伤后应激障碍和其他止痛药的使用。我们期望获得关于如何最好地将ACT作为需要手术的退伍军人常规护理的一部分的重要知识,以及ACT在预防手术后持续疼痛和长时间阿片类药物使用方面的初步功效。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Barbara Rakel其他文献

Barbara Rakel的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Barbara Rakel', 18)}}的其他基金

Effectiveness of TENS on Hyperalgesia, Pain with Movement, and Function After TKR
TENS 对 TKR 后痛觉过敏、运动疼痛和功能的有效性
  • 批准号:
    8069656
  • 财政年份:
    2010
  • 资助金额:
    $ 33.98万
  • 项目类别:
Effectiveness of TENS on Hyperalgesia, Pain with Movement, and Function After TKR
TENS 对 TKR 后痛觉过敏、运动疼痛和功能的有效性
  • 批准号:
    7849100
  • 财政年份:
    2009
  • 资助金额:
    $ 33.98万
  • 项目类别:
Effect of TENS on Knee Osteoarthritis Pain, Hyperalgesia, and Function
TENS 对膝骨关节炎疼痛、痛觉过敏和功能的影响
  • 批准号:
    7289659
  • 财政年份:
    2007
  • 资助金额:
    $ 33.98万
  • 项目类别:
Effectiveness of TENS on Hyperalgesia, Pain with Movement, and Function After TKR
TENS 对 TKR 后痛觉过敏、运动疼痛和功能的有效性
  • 批准号:
    7634509
  • 财政年份:
    2007
  • 资助金额:
    $ 33.98万
  • 项目类别:
Effectiveness of TENS on Hyperalgesia, Pain with Movement, and Function After TKR
TENS 对 TKR 后痛觉过敏、运动疼痛和功能的有效性
  • 批准号:
    7478019
  • 财政年份:
    2007
  • 资助金额:
    $ 33.98万
  • 项目类别:
Effectiveness of TENS on Hyperalgesia, Pain with Movement, and Function After TKR
TENS 对 TKR 后痛觉过敏、运动疼痛和功能的有效性
  • 批准号:
    7849084
  • 财政年份:
    2007
  • 资助金额:
    $ 33.98万
  • 项目类别:
Effectiveness of TENS on Hyperalgesia, Pain with Movement, and Function After TKR
TENS 对 TKR 后痛觉过敏、运动疼痛和功能的有效性
  • 批准号:
    7263409
  • 财政年份:
    2007
  • 资助金额:
    $ 33.98万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 33.98万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.98万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 33.98万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.98万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 33.98万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 33.98万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.98万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 33.98万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 33.98万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.98万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了